Literature DB >> 33861996

The flow of sickle blood in glass capillaries: Fundamentals and potential applications.

Christopher D Brown1, Alexey M Aprelev1, Maura Aliprando1, Emily A Harkness1, Frank A Ferrone2.   

Abstract

We have characterized the imbibed horizontal flow of sickle blood into 100-μm-diameter glass capillaries. We find that blood containing sickled cells typically traverses the capillaries between three and four times as slowly as oxygenated cells from the same patient for all genotypes tested, including SS, AS, SC and Sβ+ thalassemia blood. Blood from SS patients treated with hydroxyurea has a viscosity intermediate between the SS and AA values. Blood containing cells that are not rigidified, such as normal red cells or oxygenated sickle cells, follows a simple Lucas-Washburn flow throughout the length of the 3-cm capillary. By fitting the flexible-cell data to the Lucas-Washburn model, a viscosity can be derived that is in good agreement with previous measurements over a range of volume fractions and is obtained using an apparatus that is far more complex. Deoxygenation sickles and thus rigidifies the cells, and their flow begins as Lucas-Washburn, albeit with higher viscosity than flexible cells. However, the flow further slows as a dense mass of cells forms behind the meniscus and increases in length as flow progresses. By assuming that the dense mass of cells exerts a frictional force proportional to its length, we derive an equation that is formally equivalent to vertical imbibition, even though the flow is horizontal, and this equation reproduces the observed behavior well. We present a simple theory using activity coefficients that accounts for this viscosity and its variation without adjustable parameters. In the course of control experiments, we have found that deoxygenation increases the flexibility of normal human red cells, an observation only recently published for mouse cells and previously unreported for human erythrocytes. Together, these studies form the foundation for an inexpensive and rapid point-of-care device to diagnose sickle cell disease or to determine blood viscosity in resource-challenged settings.
Copyright © 2021 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33861996      PMCID: PMC8390806          DOI: 10.1016/j.bpj.2021.03.040

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   3.699


  36 in total

1.  Rheology of human blood, near and at zero flow. Effects of temperature and hematocrit level.

Authors:  E W MERRILL; E R GILLILAND; G COKELET; H SHIN; A BRITTEN; R E WELLS
Journal:  Biophys J       Date:  1963-05       Impact factor: 4.033

2.  An accurate and inexpensive color-based assay for detecting severe anemia in a limited-resource setting.

Authors:  Patrick T McGann; Erika A Tyburski; Vysolela de Oliveira; Brigida Santos; Russell E Ware; Wilbur A Lam
Journal:  Am J Hematol       Date:  2015-10-12       Impact factor: 10.047

Review 3.  Sickle cell hemoglobin polymerization.

Authors:  W A Eaton; J Hofrichter
Journal:  Adv Protein Chem       Date:  1990

4.  Paper-Based Diagnostics: Rethinking Conventional Sickle Cell Screening to Improve Access to High-Quality Health Care in Resource-Limited Settings.

Authors:  Nathaniel Z Piety; Sergey S Shevkoplyas
Journal:  IEEE Pulse       Date:  2017 May-Jun       Impact factor: 0.924

5.  Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.

Authors:  M H Gaston; J I Verter; G Woods; C Pegelow; J Kelleher; G Presbury; H Zarkowsky; E Vichinsky; R Iyer; J S Lobel
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

6.  A rapid paper-based test for quantifying sickle hemoglobin in blood samples from patients with sickle cell disease.

Authors:  Nathaniel Z Piety; Xiaoxi Yang; Dalia Lezzar; Alex George; Sergey S Shevkoplyas
Journal:  Am J Hematol       Date:  2015-03-30       Impact factor: 10.047

7.  A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy.

Authors:  K R Bridges; G D Barabino; C Brugnara; M R Cho; G W Christoph; G Dover; B M Ewenstein; D E Golan; C R Guttmann; J Hofrichter; R V Mulkern; B Zhang; W A Eaton
Journal:  Blood       Date:  1996-12-15       Impact factor: 22.113

8.  Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.

Authors:  Natasha B Halasa; Sadhna M Shankar; Thomas R Talbot; Patrick G Arbogast; Ed F Mitchel; Winfred C Wang; William Schaffner; Allen S Craig; Marie R Griffin
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079

9.  Validation of a novel point of care testing device for sickle cell disease.

Authors:  Julie Kanter; Marilyn J Telen; Carolyn Hoppe; Christopher L Roberts; Jason S Kim; Xiaoxi Yang
Journal:  BMC Med       Date:  2015-09-16       Impact factor: 8.775

10.  COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?

Authors:  Cheryl L Maier; Alexander D Truong; Sara C Auld; Derek M Polly; Christin-Lauren Tanksley; Alexander Duncan
Journal:  Lancet       Date:  2020-05-25       Impact factor: 79.321

View more
  2 in total

Review 1.  Oscillators in the microvasculature: glycocalyx and beyond.

Authors:  Michael S Goligorsky
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-27       Impact factor: 5.282

2.  Biomechanical properties of endothelial glycocalyx: An imperfect pendulum.

Authors:  Xi Zhuo Jiang; Michael S Goligorsky
Journal:  Matrix Biol Plus       Date:  2021-10-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.